2.139USD-2.79%Mkt Cap: 8.95M USDP/E: —Last update: 2026-06-01
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap8.95M USD
Enterprise Value7.08M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-14.50M USD
Revenue/Share—
Last Price2.139 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.16
PEG5.03
EV/EBITDA-0.49
EV/Revenue—
P/S—
P/B3.26
EPS (TTM)-4.52
EPS (Forward)-1.87
52W Range
2.0800% of range41.22
52W High41.22 USD
52W Low2.080 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-205.26%
ROA-117.96%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.90M USD
CapEx (TTM)280.57K USD
FCF Margin—
FCF Yield—
Net Debt-3.88M USD
Net Debt/EBITDA0.27
Balance Sheet
Debt/Equity0.14
Current Ratio1.59
Quick Ratio1.15
Book Value/Sh0.6680 USD
Cash/Share0.9530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split115:100
Split DateAug 7, 2025
Analyst Consensus
Rating—
Target (Mean)17.60 USD
Target Range10.00 USD – 25.00 USD
# Analysts5
Ownership
Shares Out.4.20M
Float4.55M
Insiders0.59%
Institutions11.99%
Short Interest
Short Ratio4.1d
Short % Float3.52%
Short % Out.3.49%
Shares Short146.86K
Short (prev mo.)142.26K
Technical
SMA 502.779 (-23.0%)
SMA 2003.941 (-45.7%)
Beta2.03
S&P 52W Chg27.94%
Avg Vol (30d)42.11K
Avg Vol (10d)53.85K
Technical Indicators
RSI (14)29.1
MACD-0.1779
MACD Signal-0.1693
MACD Hist.-0.0085
BB Upper2.986 USD
BB Middle2.481 USD
BB Lower1.976 USD
BB Width40.70%
ATR (14)0.1843 USD
Vol Ratio (20d)1.71x